Cite
HARVARD Citation
Wen, F. et al. (n.d.). Which is false: Oxaliplatin or fluoropyrimidine? An analysis of patients with KRAS wild‐type metastatic colorectal cancer treated with first‐line epidermal growth factor receptor monoclonal antibody. Cancer science. 104 (10), pp. 1330-1338. [Online].